CIK 0001833769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,545
- in 2 filings
Net −$12,545. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Sainz Maria President and CEO | Grant or award | +750,000 | 789,586 | ||
| 2024-03-28 | Sainz Maria President and CEO | Grant or award · Stock Option (right to buy) | +1,435,000 | 1,435,000 | ||
| 2022-12-14 | Sainz Maria President and CEO | Purchase | +5,000 | $0.95 | $5K | 39,425 |
| 2022-12-09 | Sainz Maria President and CEO | Purchase | +12,425 | $0.85 | $11K | 34,425 |
| 2022-12-09 | Sainz Maria President and CEO | Grant or award | +12,425 | $0.85 | $11K | 34,425 |
| 2022-12-08 | Sainz Maria President and CEO | Purchase | +2,575 | $0.83 | $2K | 22,161 |
| 2022-12-08 | Sainz Maria President and CEO | Grant or award | +2,575 | $0.83 | $2K | 22,161 |
| 2022-10-31 | Sainz Maria President and CEO | Grant or award · Stock Option (right to buy) | +3,175,000 | 3,175,000 | ||
| 2022-06-09 | Sainz Maria Director | Grant or award · Stock Options (right to buy) | +85,345 | 85,345 | ||
| 2021-12-23 | Sainz Maria Director | Grant or award | +19,586 | 19,586 | ||
| 2021-12-23 | Sainz Maria Director | Grant or award | +16,483 | 16,483 |
Page 1 of 1 · 11 trades